Despite AI’s massive impact on the world, most models are still designed mainly for English and a few other languages. This leaves large parts of the world underserved, especially India, where more than 1.5 billion people speak Indic languages. To address this gap, BharatGen—an initiative funded by India’s Department of Science and Technology and based at IIT Bombay—has created models for 14 of the most widely spoken languages, with plans to cover many more. And, IBM (IBM) is now partnering with BharatGen to accelerate this work.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Indeed, the new partnership between IBM and BharatGen is meant to scale AI adoption across India, with a focus on multimodal and large language models that can handle Indic languages effectively. Interestingly, the collaboration builds on an earlier connection, when BharatGen researchers met IBM teams at an AI Alliance event in India. At that event, IBM Research demonstrated its InstructLab tool for fine-tuning smaller models in Indic languages, which helped lead to the new agreement.
Together, IBM and BharatGen will create applications for industries such as education, agriculture, banking, healthcare, and citizen services. They plan to integrate BharatGen’s sovereign models with IBM’s Granite models, and use IBM’s watsonx platform and Red Hat OpenShift AI to build scalable, open-source data pipelines. In addition, IBM’s focus on governance will help make sure that these models meet India’s national and commercial needs while remaining safe and transparent.
Is IBM a Buy, Sell, or Hold?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on seven Buys, six Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $296 per share implies 11.1% upside potential.
See more IBM analyst ratings
Disclaimer & DisclosureReport an Issue